Načítá se...
F5-peptide enhances the efficacy of the non-hormonal male contraceptive adjudin
OBJECTIVE. The bioavailability of the non-hormonal male contraceptive adjudin is low in rats due to the blood-testis barrier (BTB). This study was designed to examine if F5-peptide, an endogenously produced reversible BTB modifier, could enhance the bioavailability of adjudin to affect spermatogenes...
Uloženo v:
| Vydáno v: | Contraception |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790069/ https://ncbi.nlm.nih.gov/pubmed/30763581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2019.01.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|